156 related articles for article (PubMed ID: 27865933)
1. Mechanistic analysis of triamcinolone acetonide release from PLGA microspheres as a function of varying in vitro release conditions.
Doty AC; Zhang Y; Weinstein DG; Wang Y; Choi S; Qu W; Mittal S; Schwendeman SP
Eur J Pharm Biopharm; 2017 Apr; 113():24-33. PubMed ID: 27865933
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of in vivo release of triamcinolone acetonide from PLGA microspheres.
Doty AC; Weinstein DG; Hirota K; Olsen KF; Ackermann R; Wang Y; Choi S; Schwendeman SP
J Control Release; 2017 Jun; 256():19-25. PubMed ID: 28342981
[TBL] [Abstract][Full Text] [Related]
3. Validation of a cage implant system for assessing in vivo performance of long-acting release microspheres.
Doty AC; Hirota K; Olsen KF; Sakamoto N; Ackermann R; Feng MR; Wang Y; Choi S; Qu W; Schwendeman A; Schwendeman SP
Biomaterials; 2016 Dec; 109():88-96. PubMed ID: 27693924
[TBL] [Abstract][Full Text] [Related]
4. Characterizing release mechanisms of leuprolide acetate-loaded PLGA microspheres for IVIVC development I: In vitro evaluation.
Hirota K; Doty AC; Ackermann R; Zhou J; Olsen KF; Feng MR; Wang Y; Choi S; Qu W; Schwendeman AS; Schwendeman SP
J Control Release; 2016 Dec; 244(Pt B):302-313. PubMed ID: 27565212
[TBL] [Abstract][Full Text] [Related]
5. Effect of PLGA raw materials on in vitro and in vivo performance of drug-loaded microspheres.
Liang D; Walker J; Schwendeman PS; Chandrashekar A; Ackermann R; Olsen KF; Beck-Broichsitter M; Schwendeman SP
Drug Deliv Transl Res; 2024 Apr; ():. PubMed ID: 38643259
[TBL] [Abstract][Full Text] [Related]
6. Effect of acidic pH on PLGA microsphere degradation and release.
Zolnik BS; Burgess DJ
J Control Release; 2007 Oct; 122(3):338-44. PubMed ID: 17644208
[TBL] [Abstract][Full Text] [Related]
7. Flow-through cell-based in vitro release method for triamcinolone acetonide poly (lactic-co-glycolic) acid microspheres.
Tipnis NP; Shen J; Jackson D; Leblanc D; Burgess DJ
Int J Pharm; 2020 Apr; 579():119130. PubMed ID: 32070759
[TBL] [Abstract][Full Text] [Related]
8. Mapping in vivo microclimate pH distribution in exenatide-encapsulated PLGA microspheres.
Hong JKY; Schutzman R; Olsen K; Chandrashekar A; Schwendeman SP
J Control Release; 2022 Dec; 352():438-449. PubMed ID: 36030989
[TBL] [Abstract][Full Text] [Related]
9. An Accelerated Release Method of Risperidone Loaded PLGA Microspheres with Good IVIVC.
Hu X; Zhang J; Tang X; Li M; Ma S; Liu C; Gao Y; Zhang Y; Liu Y; Yu F; Yang Y; Guo J; Li Z; Mei X
Curr Drug Deliv; 2018; 15(1):87-96. PubMed ID: 28521697
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of in vivo-in vitro release of dexamethasone from PLGA microspheres.
Zolnik BS; Burgess DJ
J Control Release; 2008 Apr; 127(2):137-45. PubMed ID: 18282629
[TBL] [Abstract][Full Text] [Related]
11. Seeing is believing, PLGA microsphere degradation revealed in PLGA microsphere/PVA hydrogel composites.
Gu B; Sun X; Papadimitrakopoulos F; Burgess DJ
J Control Release; 2016 Apr; 228():170-178. PubMed ID: 26965956
[TBL] [Abstract][Full Text] [Related]
12. Elevated temperature accelerated release testing of PLGA microspheres.
Zolnik BS; Leary PE; Burgess DJ
J Control Release; 2006 May; 112(3):293-300. PubMed ID: 16644055
[TBL] [Abstract][Full Text] [Related]
13. Prediction of dexamethasone release from PLGA microspheres prepared with polymer blends using a design of experiment approach.
Gu B; Burgess DJ
Int J Pharm; 2015 Nov; 495(1):393-403. PubMed ID: 26325309
[TBL] [Abstract][Full Text] [Related]
14. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
15. The effect of lauryl capping group on protein release and degradation of poly(D,L-lactic-co-glycolic acid) particles.
Samadi N; Abbadessa A; Di Stefano A; van Nostrum CF; Vermonden T; Rahimian S; Teunissen EA; van Steenbergen MJ; Amidi M; Hennink WE
J Control Release; 2013 Dec; 172(2):436-43. PubMed ID: 23751568
[TBL] [Abstract][Full Text] [Related]
16. Donepezil accelerates the release of PLGA microparticles via catalyzing the polymer degradation regardless of the end groups and molecular weights.
Quan P; Guo W; LinYang ; Cun D; Yang M
Int J Pharm; 2023 Feb; 632():122566. PubMed ID: 36586633
[TBL] [Abstract][Full Text] [Related]
17. Setting accelerated dissolution test for PLGA microspheres containing peptide, investigation of critical parameters affecting drug release rate and mechanism.
Tomic I; Vidis-Millward A; Mueller-Zsigmondy M; Cardot JM
Int J Pharm; 2016 May; 505(1-2):42-51. PubMed ID: 27025293
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir.
Duvvuri S; Janoria KG; Mitra AK
J Control Release; 2005 Nov; 108(2-3):282-93. PubMed ID: 16229919
[TBL] [Abstract][Full Text] [Related]
19. In vitro-in vivo correlation of PLGA microspheres: Effect of polymer source variation and temperature.
Wan B; Bao Q; Burgess DJ
J Control Release; 2022 Jul; 347():347-355. PubMed ID: 35569590
[TBL] [Abstract][Full Text] [Related]
20. Monomer sequence in PLGA microparticles: Effects on acidic microclimates and in vivo inflammatory response.
Washington MA; Balmert SC; Fedorchak MV; Little SR; Watkins SC; Meyer TY
Acta Biomater; 2018 Jan; 65():259-271. PubMed ID: 29101019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
